Purchases and Sales Made in Q4 2022 in Revelation Biosciences, Inc. (REVB)
This table provides information about the institutional ownership of Revelation Biosciences, Inc. (REVB) during Q4 2022. The information is specifically focused on institutions that hold shares of REVELATION BIOSCIENCES, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 27, 2023
Q4 2022
|
Rebalance, LLC
Palo Alto, CA |
BUY
|
- |
85.8KNew |
$15.5K - $37M
|
85.8K
$73K
|
|
|
Jan 25, 2023
Q4 2022
|
Mayflower Financial Advisors, LLC
|
BUY
|
- |
21.4KNew |
$3.86K - $9.25M
|
21.4K
$18.2K
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
17.7K+ 81.16% |
$3.18K - $7.62M
|
39.4K
$33.5K
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 3.48% |
$0.72 - $1.73K
|
119
$101
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-312- 3.55% |
$56.2 - $135K
|
8.47K
$7.2K
|